Schreck, K. C., Fuente, M. I. D. L., Rine, J., Kline, I., Shephard, S. P., Ahnert, J. R., Sherman, E. J., Yaeger, R. (2025). FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2091